Database

Startups

Main Industry
Health Care
Main Product/Service
FattyTouch Ultrasound Fatty Liver Diagnostic System
The content above was translated by Ai
Founded Year
2018
Unified Business No.
42981949
Status
Active
Number of Employees
0
Total capital
1,000,000 (NT$)
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups. Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed. Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
About the Company
FattyTouch: A next-generation ultrasound fatty liver diagnosis system that integrates the ultrasound scattering analysis technology developed by Professor Po-Hsiang Tsui's team from the Department of Medical Imaging and Radiological Sciences at Chang Gung University into standard clinical ultrasound systems, achieving a fatty liver diagnosis and evaluation strategy characterized by rapid market adoption, mobile accessibility, simplicity, and effectiveness. FattyTouch provides users with abdominal ultrasound scanning capabilities and objective quantitative analysis of fatty liver severity, thereby enhancing and supporting the diagnostic reliability and subsequent intervention decisions of clinical users to achieve the goal of precision medicine. Furthermore, in alignment with contemporary trends in preventive medicine and comprehensive health platforms, FattyTouch can be utilized to develop fatty liver screening and subsequent long-term health tracking and management platforms. It can also be paired with the development of new drugs for fatty liver treatment to serve as a tool for validating product efficacy.


The content above was translated by Ai
more ↓

Similar Companies

回頁面最頂端